Promising results found for treatment of melanoma in the brain
At the American Society of Clinical Oncology Annual Meeting 2017 in Chicago, researchers presented promising data for two different investigational drug regimens used to treat melanoma that has spread to the brain, a common and deadly complication of this cancer.
For anorexia nervosa, researchers implicate genetic locus on chromo...
UNC researchers led the most powerful genomic study of anorexia nervosa conducted to date to identify the common roots anorexia shares with psychiatric and metabolic traits. Cynthia Bulik, PhD, FAED, was the study's lead investigator.
“We are not our disease”: UNC Horizons celebrates 23 years of heali...
UNC and surrounding communities gathered together on Wednesday to celebrate the grand opening of the new facility for UNC Horizons at Shelton Station in downtown Carrboro. UNC Horizons has been treating new and expecting mothers with substance use disorders, while keeping the mother-child dyad intac
UNC researchers link orphan receptor to opioid-induced itching
With a more accurate understanding of the characteristics and function of the receptor MRGRPX2, University of North Carolina School of Medicine researchers were also able to create chemical probe that will allow them study the receptor more precisely.
Infant MRIs show autism linked to increased cerebrospinal fluid
MRIs show a brain anomaly in nearly 70 percent of babies at high risk of developing the condition who go on to be diagnosed, laying the groundwork for a predictive aid for pediatricians and the search for a potential treatment.
UNC researchers campaign for new funding to treat VTE
UNC’s Nigel Key and Alisa Wolberg labs were featured in a recent video produced by the American Society of Hematology to urge continued National Institutes of Health support for ongoing research of venous thromboembolism and other hematologic conditions.